A calculation error related to the Rule of 6 may have contributed to an infant's death recently when it led to a misplaced decimal point and the preparation of a ...
1–3 Potentially serious toxic effects include opioid-induced respiratory depression ... This is an important potential barrier to safe dose calculation and may explain why confusion and a ‘best guess’ ...
Non-opioid analgesic drugs were the most frequent group of medications ... adherence to double checking steps during the medication administration process. Drug dose calculation was only double ...
This morning, at the annual Education & Training Awards breakfast, the NYC Building & Construction Industry Safety Fund ...
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
A professor and his team at University of the Pacific have developed a single-dose treatment that provides extended ...
There was an increased risk of death among veterans who started opioid treatment at a higher dosage, compared to those who started at a lower dosage. There was an increased risk of death among ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...
An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...
Moreover, clinical data from Phase 1 studies suggested that AV-101 is well-tolerated, with no significant adverse events reported at any dose level compared to a placebo. While the company ...